- Bloomberg•4 days ago
A U.S. Food & Drug Administration inspection of Sun Pharmaceutical Industries Ltd.’s facility in Halol, India, has given rise to a 14-page inspection report that could list potential violations of the ...
- TheStreet.com•17 days ago
The India pharma giant also purchases an 85.1% interest in Biosintez for $60 million.
- PR Newswire•2 months agoSun Pharma to Announce Late-Breaking Results for Investigational IL-23p19 inhibitor, Tildrakizumab, Achieves Primary End Point in Both Phase-3 Studies in Patients with Moderate-to-Severe Plaque Psoriasis
MUMBAI, India and PRINCETON, N.J., Oct. 1, 2016 /PRNewswire/ -- Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries ...
SUNPHARMA.NS : Summary for SUN PHARMACEUTICAL INR1(DEMAT) - Yahoo Finance
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
NSE - NSE Delayed Price. Currency in INR
Add to watchlist
|Day's Range||671.25 - 682.80|
|52 Week Range||571.90 - 898.45|
|PE Ratio (TTM)||21.94|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|